Home/Filings/4/0001562180-24-000364
4//SEC Filing

Leschly Nick 4

Accession 0001562180-24-000364

CIK 0001860782other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:08 PM ET

Size

10.7 KB

Accession

0001562180-24-000364

Insider Transaction Report

Form 4
Period: 2024-01-05
Leschly Nick
Director
Transactions
  • Sale

    Common Stock

    2024-01-05$3.75/sh1,554$5,8331,085,476 total
  • Award

    Common Stock

    2024-01-08+235,0001,320,476 total
  • Award

    Stock Option (Right to buy)

    2024-01-08+469,000469,000 total
    Exercise: $3.97Exp: 2034-01-08Common Stock (469,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    41,000
  • Common Stock

    (indirect: By Trust)
    15,233
Footnotes (4)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units ("RSUs").
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.675 to $3.83, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]RSU awards vest over a four-year period at the rate of 25% on 01/02/2025, 25% on 01/02/2026, 25% on 01/02/2027, and 25% on 01/02/2028.
  • [F4]This stock option vests over a four-year period at the rate of 25% on 01/02/2025, and then in 36 equal monthly installments thereafter.

Issuer

2seventy bio, Inc.

CIK 0001860782

Entity typeother

Related Parties

1
  • filerCIK 0001578408

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:08 PM ET
Size
10.7 KB